SR 11302
Tocris Bioscience, part of Bio-Techne | Catalog # 2476
AP-1 inhibitor; antitumor agent
Product Description
SR 11302 is an inhibitor of activator protein-1 (AP-1) transcription factor activity that displays antitumor effects in vivo. Does not activate transcription from the retinoic acid response element (RARE) and displays no activity at retinoic acid receptors (EC50 > 1 μM for RARα, RARβ, RARγ and RXRα).Product Specifications
Molecular Weight
376.54
Formula
C26H32O2
Storage
Store at -20°C
Purity
≥95% (HPLC)
Chemical Name
(E,E,Z,E)-3-Methyl-7-(4-methylphenyl)-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
CAS Number
160162-42-5
PubChem ID
9976842
InChI Key
RQANARBNMTXCDM-DKOHIBGUSA-N
SMILES
CC(\C=C\C=C(\C=C\C1=C(C)CCCC1(C)C)C1=CC=C(C)C=C1)=C/C(O)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 37.6 | 100 | |
| Ethanol | 3.76 | 10 |
Preparing Stock Solutions
for SR 11302
The following data is based on the product molecular weight 376.54
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.66 mL | 13.28 mL | 26.56 mL |
| 5 mM | 0.53 mL | 2.66 mL | 5.31 mL |
| 10 mM | 0.27 mL | 1.33 mL | 2.66 mL |
| 50 mM | 0.05 mL | 0.27 mL | 0.53 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Huang Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc.Natl.Acad.Sci.USA
- Fanjul A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 1994 PMID: 7969403
- Shiohara Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood 1999 PMID: 10068679
Product Specific Notices for SR 11302
For research use only
Loading...
Loading...
Loading...